This unique collaboration and technology has established leading imaging/radiopharmaceutical solutions that accelerates development. The production team that is directed by industry leaders in their respective areas of specialty offers a breadth of imaging capabilities that are comprehensive.

In building this world-class translational imaging center in Mattawan, Michigan, this unique resource will accelerate the next generation of breakthrough therapeutics. The 10,000 square foot addition features the first commercially available cyclotron, which uses radioisotopes in molecular imaging to track distribution and efficacy in drug candidates. These industry leaders can provide magnetic resonance and translational nuclear imaging (PET and SPECT) for both small and large molecules from mouse to nonhuman primates, and through to the clinic. This offers potential to reduce the number of trials and test subjects, resulting in reduced costs and optimum speed-to-market for Sponsors.

Taking you further!